id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0439-0007,FDA,FDA-2006-E-0439,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-10-24T04:00:00Z,2007,10,,,2026-01-08T01:15:09Z,,0,0,0900006480461ec7
FDA-2006-E-0439-0006,FDA,FDA-2006-E-0439,Determination of Regulatory Review Period for Purposes of Patent Extension; NOVOLOG,Notice,General Notice,2007-03-26T04:00:00Z,2007,3,2007-03-26T04:00:00Z,,2026-01-08T01:13:19Z,E7-5445,0,0,0900006480461ec5
FDA-2006-E-0439-0005,FDA,FDA-2006-E-0439,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2007-03-13T04:00:00Z,2007,3,,,2026-01-08T01:08:45Z,,0,0,0900006480461ec3
FDA-2006-E-0439-0004,FDA,FDA-2006-E-0439,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2007-01-25T05:00:00Z,2007,1,,,2026-01-08T00:53:42Z,,0,0,0900006480461ec2